| 000 | 01277 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250515153823.0 | ||
| 264 | 0 | _c20090226 | |
| 008 | 200902s 0 0 ger d | ||
| 022 | _a0720-9355 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aScharf, R E | |
| 245 | 0 | 0 |
_a[Acquired platelet function disorders: pathogenesis, classification, frequency, diagnosis, clinical management]. _h[electronic resource] |
| 260 |
_bHamostaseologie _cDec 2008 |
||
| 300 |
_a299-311 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article; Review | ||
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xadverse effects |
| 650 | 0 | 4 |
_aAspirin _xadverse effects |
| 650 | 0 | 4 |
_aBlood Platelet Disorders _xchemically induced |
| 650 | 0 | 4 |
_aBlood Platelets _xphysiology |
| 650 | 0 | 4 |
_aCoronary Disease _xblood |
| 650 | 0 | 4 |
_aHemorrhage _xchemically induced |
| 650 | 0 | 4 |
_aHemostasis _xdrug effects |
| 650 | 0 | 4 |
_aHemostatic Disorders _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver Cirrhosis _xblood |
| 650 | 0 | 4 |
_aMyocardial Infarction _xblood |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aRenal Insufficiency _xblood |
| 650 | 0 | 4 |
_aThrombocytopenia _xblood |
| 773 | 0 |
_tHamostaseologie _gvol. 28 _gno. 5 _gp. 299-311 |
|
| 999 |
_c18581103 _d18581103 |
||